Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease Trial Phase 1 Not yet recruiting Oct. 19, 2026
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD Trial N/A Recruiting Oct. 19, 2026
Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease Trial N/A Terminated Oct. 19, 2026
Utilization of Aerobic Exercise to Maintain Neurologic Health Trial N/A Not yet recruiting Oct. 19, 2026
Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl Trial N/A Recruiting Oct. 19, 2026
EXercise-induced PhysioLogical Adaptations In Neurological Disorders Trial N/A Recruiting Oct. 19, 2026
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease Trial N/A Recruiting Oct. 19, 2026
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease Trial N/A Active, not recruiting Oct. 19, 2026
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients. Trial Phase 1 Recruiting Oct. 19, 2026
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD) Trial Phase 1 Recruiting Oct. 18, 2026
The Effects of Tele-Rehabilitation-Based Dual-Task Upper Extremity Training in Patients With Parkinson's Disease Trial N/A Recruiting Oct. 18, 2026
Slow Wave Sleep as a Biomarker of Rehabilitation-induced Cognitive Improvement in PD Trial N/A Active, not recruiting Oct. 18, 2026
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease Trial Phase 1 Recruiting Oct. 15, 2026
Primary Parkinsonian Pain: Clinical Association and Phenotype Trial N/A Not yet recruiting Oct. 15, 2026
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease Trial Phase 2 Recruiting Oct. 15, 2026
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease Trial Phase 1 Recruiting Oct. 15, 2026
A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects With Early Parkinson's Disease Trial Phase 2 Not yet recruiting Oct. 15, 2026